Q9UQD0 (SCN8A_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 112.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Sodium channel protein type 8 subunit alpha Alternative name(s): Sodium channel protein type VIII subunit alpha Voltage-gated sodium channel subunit alpha Nav1.6 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1980 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which Na+ ions may pass in accordance with their electrochemical gradient. In macrophages and melanoma cells, isoform 5 may participate in the control of podosome and invadopodia formation. Ref.3 |
| Subunit structure | Interacts with NEDD4 and NEDD4L By similarity. Interacts with FGF13; may regulate SCN8A activity. Ref.7 |
| Subcellular location | Membrane; Multi-pass membrane protein Ref.3. Isoform 5: Cytoplasmic vesicle. Note: Some vesicles are localized adjacent to melanoma invadopodia and macrophage podosomes. Does not localize to the plasma membrane. Ref.3 |
| Tissue specificity | Isoform 5 is expressed in non-neuronal tissues, such as monocytes/macrophages. Ref.3 |
| Domain | The sequence contains 4 internal repeats, each with 5 hydrophobic segments (S1,S2,S3,S5,S6) and one positively charged segment (S4). Segments S4 are probably the voltage-sensors and are characterized by a series of positively charged amino acids at every third position. |
| Post-translational modification | May be ubiquitinated by NEDD4L; which would promote its endocytosis By similarity. |
| Involvement in disease | Cognitive impairment with or without cerebellar ataxia (CIAT) [MIM:614306]: A disorder characterized by markedly delayed cognitive and motor development, attention deficit disorder, and cerebellar ataxia. Features include bilateral esophoria, strabismatic amblyopia, unsustained gaze evoked nystagmus on horizontal gaze, ataxic gait, dysmetria in the upper limbs and dysarthria, with normal strength, tone, and reflexes. Epileptic encephalopathy, early infantile, 13 (EIEE13) [MIM:614558]: A form of epilepsy characterized by frequent tonic seizures or spasms beginning in infancy with a specific EEG finding of suppression-burst patterns, characterized by high-voltage bursts alternating with almost flat suppression phases. Patients may progress to West syndrome, which is characterized by tonic spasms with clustering, arrest of psychomotor development, and hypsarrhythmia on EEG. EIEE13 is a severe form consisting of early-onset seizures, features of autism, intellectual disability, ataxia, and sudden unexplained death in epilepsy. |
| Sequence similarities | Belongs to the sodium channel (TC 1.A.1.10) family. Nav1.6/SCN8A subfamily. [View classification] Contains 1 IQ domain. |
Ontologies
Alternative products
| This entry describes 5 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 Ref.2 (identifier: Q9UQD0-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 Ref.2 (identifier: Q9UQD0-2) Also known as: 5A; The sequence of this isoform differs from the canonical sequence as follows: 207-207: I → V 212-212: N → D | ||||||
| Isoform 3 Ref.2 (identifier: Q9UQD0-3) The sequence of this isoform differs from the canonical sequence as follows: 666-666: E → EVKIDKAATDDS | ||||||
| Isoform 4 Ref.1 (identifier: Q9UQD0-4) Also known as: 18N; The sequence of this isoform differs from the canonical sequence as follows: 1275-1283: SLVSLIANA → PLNLSGLI 1284-1980: Missing. | ||||||
| Isoform 5 (identifier: Q9UQD0-5) The sequence of this isoform differs from the canonical sequence as follows: 1275-1315: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1980 | 1980 | Sodium channel protein type 8 subunit alpha | PRO_0000048500 | |||||
Regions | |||||||||
| Transmembrane | 128 – 151 | 24 | Helical; Name=S1 of repeat I; Potential | ||||||
| Transmembrane | 160 – 179 | 20 | Helical; Name=S2 of repeat I; Potential | ||||||
| Transmembrane | 193 – 211 | 19 | Helical; Name=S3 of repeat I; Potential | ||||||
| Transmembrane | 218 – 237 | 20 | Helical; Voltage-sensor; Name=S4 of repeat I; Potential | ||||||
| Transmembrane | 253 – 277 | 25 | Helical; Name=S5 of repeat I; Potential | ||||||
| Transmembrane | 388 – 413 | 26 | Helical; Name=S6 of repeat I; Potential | ||||||
| Transmembrane | 748 – 772 | 25 | Helical; Name=S1 of repeat II; Potential | ||||||
| Transmembrane | 784 – 807 | 24 | Helical; Name=S2 of repeat II; Potential | ||||||
| Transmembrane | 816 – 835 | 20 | Helical; Name=S3 of repeat II; Potential | ||||||
| Transmembrane | 842 – 862 | 21 | Helical; Voltage-sensor; Name=S4 of repeat II; Potential | ||||||
| Transmembrane | 878 – 898 | 21 | Helical; Name=S5 of repeat II; Potential | ||||||
| Transmembrane | 952 – 977 | 26 | Helical; Name=S6 of repeat II; Potential | ||||||
| Transmembrane | 1194 – 1217 | 24 | Helical; Name=S1 of repeat III; Potential | ||||||
| Transmembrane | 1231 – 1256 | 26 | Helical; Name=S2 of repeat III; Potential | ||||||
| Transmembrane | 1263 – 1284 | 22 | Helical; Name=S3 of repeat III; Potential | ||||||
| Transmembrane | 1289 – 1310 | 22 | Helical; Voltage-sensor; Name=S4 of repeat III; Potential | ||||||
| Transmembrane | 1330 – 1351 | 22 | Helical; Name=S5 of repeat III; Potential | ||||||
| Transmembrane | 1438 – 1464 | 27 | Helical; Name=S6 of repeat III; Potential | ||||||
| Transmembrane | 1518 – 1541 | 24 | Helical; Name=S1 of repeat IV; Potential | ||||||
| Transmembrane | 1553 – 1576 | 24 | Helical; Name=S2 of repeat IV; Potential | ||||||
| Transmembrane | 1583 – 1606 | 24 | Helical; Name=S3 of repeat IV; Potential | ||||||
| Transmembrane | 1617 – 1638 | 22 | Helical; Voltage-sensor; Name=S4 of repeat IV; Potential | ||||||
| Transmembrane | 1654 – 1676 | 23 | Helical; Name=S5 of repeat IV; Potential | ||||||
| Transmembrane | 1742 – 1766 | 25 | Helical; Name=S6 of repeat IV; Potential | ||||||
| Repeat | 114 – 442 | 329 | I | ||||||
| Repeat | 735 – 1007 | 273 | II | ||||||
| Repeat | 1180 – 1495 | 316 | III | ||||||
| Repeat | 1504 – 1801 | 298 | IV | ||||||
| Domain | 1895 – 1924 | 30 | IQ | ||||||
| Nucleotide binding | 893 – 900 | 8 | ATP Potential | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 215 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 289 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 295 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 308 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 326 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 544 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 640 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 877 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 1047 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 1064 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 1091 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 1358 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 1372 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 1383 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 1768 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Alternative sequence | 207 | 1 | I → V in isoform 2. Ref.2 | VSP_050589 | |||||
| Alternative sequence | 212 | 1 | N → D in isoform 2. Ref.2 | VSP_050590 | |||||
| Alternative sequence | 666 | 1 | E → EVKIDKAATDDS in isoform 3. Ref.2 | VSP_050591 | |||||
| Alternative sequence | 1275 – 1315 | 41 | Missing in isoform 5. | VSP_038651 | |||||
| Alternative sequence | 1275 – 1283 | 9 | SLVSLIANA → PLNLSGLI in isoform 4. Ref.1 | VSP_050592 | |||||
| Alternative sequence | 1284 – 1980 | 697 | Missing in isoform 4. Ref.1 | VSP_050593 | |||||
| Natural variant | 1768 | 1 | N → D in EIEE13; gain-of-function mutation; results in increased persistent sodium currents and incomplete channel inactivation. Ref.9 | VAR_067539 | |||||
Experimental info | |||||||||
| Sequence conflict | 5 | 1 | L → V in AAF35390. Ref.5 | ||||||
| Sequence conflict | 133 | 1 | V → L in AAD15789. Ref.1 | ||||||
| Sequence conflict | 257 | 1 | L → M in AAF35390. Ref.5 | ||||||
| Sequence conflict | 273 | 1 | F → I in ACM63162. Ref.3 | ||||||
| Sequence conflict | 274 – 278 | 5 | MGNLR → HGEPS in AAF35390. Ref.5 | ||||||
| Sequence conflict | 453 | 1 | T → N in AAF35390. Ref.5 | ||||||
| Sequence conflict | 477 | 1 | S → F in AAF35390. Ref.5 | ||||||
| Sequence conflict | 483 | 1 | L → I in AAF35390. Ref.5 | ||||||
| Sequence conflict | 492 | 1 | R → S in AAF35390. Ref.5 | ||||||
| Sequence conflict | 504 | 1 | S → F in AAF35390. Ref.5 | ||||||
| Sequence conflict | 547 – 548 | 2 | LL → MF in AAF35390. Ref.5 | ||||||
| Sequence conflict | 1416 | 1 | M → V in ACM63162. Ref.3 | ||||||
| Sequence conflict | 1445 | 1 | V → I in AAD15789. Ref.1 | ||||||
| Sequence conflict | 1519 | 1 | V → I in AAD15789. Ref.1 | ||||||
| Sequence conflict | 1702 | 1 | T → A in AAF35390. Ref.5 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Alternative splicing of the sodium channel SCN8A predicts a truncated two-domain protein in fetal brain and non-neuronal cells." Plummer N.W., McBurney M.W., Meisler M.H. J. Biol. Chem. 272:24008-24015(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE (ISOFORM 4). Tissue: Brain and Fetal brain. |
| [2] | "Exon organization, coding sequence, physical mapping, and polymorphic intragenic markers for the human neuronal sodium channel gene SCN8A." Plummer N.W., Galt J., Jones J.M., Burgess D.L., Sprunger L.K., Kohrman D.C., Meisler M.H. Genomics 54:287-296(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1; 2 AND 3). |
| [3] | "Regulation of podosome formation in macrophages by a splice variant of the sodium channel SCN8A." Carrithers M.D., Chatterjee G., Carrithers L.M., Offoha R., Iheagwara U., Rahner C., Graham M., Waxman S.G. J. Biol. Chem. 284:8114-8126(2009) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. Tissue: Monocytic leukemia. |
| [4] | "cDNA sequence of human sodium channel, SCN8A." Lin C., Numakura C., Kiyoshi H. Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [5] | "Cloning of cDNA for human voltage-gated sodium channel alpha subunit, SCN8A." Jeong S.-Y., Goto J., Kanazawa I. Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [6] | "The finished DNA sequence of human chromosome 12." Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R. Gibbs R.A.Nature 440:346-351(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "Fibroblast growth factor homologous factor 2B: association with Nav1.6 and selective colocalization at nodes of Ranvier of dorsal root axons." Wittmack E.K., Rush A.M., Craner M.J., Goldfarb M., Waxman S.G., Dib-Hajj S.D. J. Neurosci. 24:6765-6775(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH FGF13. |
| [8] | "Heterozygosity for a protein truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy, ataxia, and mental retardation." Trudeau M.M., Dalton J.C., Day J.W., Ranum L.P., Meisler M.H. J. Med. Genet. 43:527-530(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN CIAT. |
| [9] | "De Novo Pathogenic SCN8A Mutation Identified by Whole-Genome Sequencing of a Family Quartet Affected by Infantile Epileptic Encephalopathy and SUDEP." Veeramah K.R., O'Brien J.E., Meisler M.H., Cheng X., Dib-Hajj S.D., Waxman S.G., Talwar D., Girirajan S., Eichler E.E., Restifo L.L., Erickson R.P., Hammer M.F. Am. J. Hum. Genet. 90:502-510(2012) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT EIEE13 ASP-1768, CHARACTERIZATION OF VARIANT EIEE13 ASP-1768. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF050736 AF050735 Genomic DNA. Translation: AAD15789.1.AF049618 Genomic DNA. Translation: AAD20439.1. FJ611941 mRNA. Translation: ACM63162.1. AB027567 mRNA. Translation: BAA78033.1. AF225988 mRNA. Translation: AAF35390.1. AC013421 Genomic DNA. No translation available. AC025097 Genomic DNA. No translation available. AC068987 Genomic DNA. No translation available. AC140060 Genomic DNA. No translation available. |
| IPI | IPI00183041. IPI00337743. IPI00337744. IPI00337745. IPI00954952. |
| RefSeq | NP_001171455.1. NM_001177984.2. NP_055006.1. NM_014191.3. |
| UniGene | Hs.436550. Hs.710638. |
3D structure databases | |
| ProteinModelPortal | Q9UQD0. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9UQD0. 1 interaction. |
| STRING | 9606.ENSP00000346534. |
Protein family/group databases | |
| TCDB | 1.A.1.10.8. voltage-gated ion channel (VIC) superfamily. |
PTM databases | |
| PhosphoSite | Q9UQD0. |
Polymorphism databases | |
| DMDM | 34098756. |
Proteomic databases | |
| PaxDb | Q9UQD0. |
| PRIDE | Q9UQD0. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000354534; ENSP00000346534; ENSG00000196876. ENST00000545061; ENSP00000440360; ENSG00000196876. |
| GeneID | 6334. |
| KEGG | hsa:6334. |
| UCSC | uc001ryw.3. human. uc010snl.2. human. |
Organism-specific databases | |
| CTD | 6334. |
| GeneCards | GC12P051987. |
| HGNC | HGNC:10596. SCN8A. |
| HPA | CAB022169. |
| MIM | 600702. gene. 614306. phenotype. 614558. phenotype. |
| neXtProt | NX_Q9UQD0. |
| Orphanet | 1934. Early infantile epileptic encephalopathy. |
| PharmGKB | PA35009. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG1226. |
| HOGENOM | HOG000231755. |
| HOVERGEN | HBG053100. |
| KO | K04840. |
| OMA | GFICKKT. |
| OrthoDB | EOG40S0DS. |
Enzyme and pathway databases | |
| Reactome | REACT_111045. Developmental Biology. |
Gene expression databases | |
| ArrayExpress | Q9UQD0. |
| Bgee | Q9UQD0. |
| CleanEx | HS_SCN8A. |
| Genevestigator | Q9UQD0. |
| GermOnline | ENSG00000196876. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR024583. DUF3451. IPR005821. Ion_trans_dom. IPR000048. IQ_motif_EF-hand-BS. IPR008054. Na_channel_a8su. IPR001696. Na_channel_asu. IPR010526. Na_trans_assoc. [Graphical view] |
| Pfam | PF11933. DUF3451. 1 hit. PF00520. Ion_trans. 4 hits. PF00612. IQ. 1 hit. PF06512. Na_trans_assoc. 1 hit. [Graphical view] |
| PRINTS | PR00170. NACHANNEL. PR01667. NACHANNEL8. |
| SMART | SM00015. IQ. 1 hit. [Graphical view] |
| PROSITE | PS50096. IQ. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | Q9UQD0. |
| ChEMBL | CHEMBL5202. |
| ChiTaRS | SCN8A. human. |
| DrugBank | DB00555. Lamotrigine. |
| GenomeRNAi | 6334. |
| NextBio | 24596. |
| SOURCE | Search... |
Entry information
| Entry name | SCN8A_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9UQD0 Secondary accession number(s): B9VWG8 Q9UPB2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
